miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme.

Oncogene
Dong YinH Phillip Koeffler

Abstract

Chromosome 1p36.23 is frequently deleted in glioblastoma multiforme (GBM). miR-34a localizes in this region. Our experiments found that miR-34a was often deleted and epidermal growth factor receptor (EGFR) was frequently amplified in genomic DNA of 55 GBMs using single-nucleotide polymorphism DNA microarray. Notably, we found that the mean survival time was significantly shortened for patients whose GBMs had both EGFR amplification and miR-34a deletion. Expression of miR-34a was significantly lower in GBM samples compared with normal brain tissue. Forced expression of miR-34a in GBM cells decreased their ability to migrate and profoundly decreased their levels of cyclin-A1, -B1, -D1, and -D3, as well as cyclin-dependent kinase and increased expression of cyclin kinase inhibitor proteins (p21, p27). Also, human GBM cells (U251) stable overexpressing mir-34a formed smaller tumors when growing as xenografts in immunodeficient mice compared with wild-type U251 GBM cells. Furthermore, the protein expression of EGFR decreased in the cells with forced overexpression of miR-34a. Additional studies showed that mir-34a targeted Yin Yang-1 (YY1) and YY1 is a transcription factor that can stimulate the expression of EGFR. Thus, our data su...Continue Reading

References

Jun 10, 1998·Oncogene·E M DuerrA von Deimling
Mar 8, 2003·Journal of Neuro-oncology·Chiara GhimentiDavide Schiffer
Jun 10, 2005·Nature·Jun LuTodd R Golub
Feb 10, 2007·Cell·Anindya BagchiAlea A Mills
Jun 2, 2007·Molecular Cell·Nina Raver-ShapiraMoshe Oren
Jun 2, 2007·Molecular Cell·Tsung-Cheng ChangJoshua T Mendell
Jun 8, 2007·Nature·Lin HeGregory J Hannon
Sep 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi TazawaHitoshi Nakagama
Oct 16, 2007·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·D L ZanetteM A Zago
Apr 3, 2008·Cancer Research·David A SolomonTodd Waldman
Apr 15, 2008·FEBS Letters·Fang SunXiaofei Zheng
May 24, 2008·Cancer Biology & Therapy·Oskar W RokhlinMichael B Cohen
May 28, 2008·Oncogene·J S WeiJ Khan
May 29, 2008·Molecular Cancer Research : MCR·Kristina A ColeJohn M Maris
Aug 23, 2008·Cell Cycle·Dmitri LodyginHeiko Hermeking
Sep 12, 2008·PloS One·Barry S TaylorChris Sander
Nov 26, 2008·Investigative Ophthalmology & Visual Science·Dongsheng YanJia Qu
Mar 4, 2009·The International Journal of Neuropsychopharmacology·Haiming ChenMelvin G McInnis
Apr 18, 2009·Genes, Chromosomes & Cancer·Galina Feinberg-GorenshteinIsaac Yaniv
Sep 24, 2009·Cancer Research·Yunqing LiRoger Abounader
Feb 18, 2010·International Journal of Cancer. Journal International Du Cancer·Dong YinH Phillip Koeffler
Mar 2, 2010·Cell Cycle·Fadila GuessousRoger Abounader
Dec 25, 2010·Journal of Proteome Research·Qing-Rong ChenJaved Khan
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Zandra HagmanYvonne Ceder

❮ Previous
Next ❯

Citations

Nov 20, 2012·Human Genomics·Ashni SedaniMeena Upadhyaya
Sep 24, 2014·Molecular Therapy. Nucleic Acids·Gabriella MissoMichele Caraglia
Jul 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M T MarinoK Scotlandi
Mar 31, 2015·Cancers·Meena Jhanwar-UniyalRaj Murali
Jan 21, 2015·Expert Opinion on Drug Delivery·Sarandeep Malhi, Xiaochen Gu
Mar 13, 2016·Brain Tumor Pathology·Arun K RoojJakub Godlewski
Mar 16, 2016·Biochimica Et Biophysica Acta·Filomena de Nigris
Mar 4, 2015·Biomarkers in Medicine·Anil Belur NagarajAnalisa DiFeo
Jul 30, 2014·BMC Cancer·Chandrani AchariChrister Larsson
Jul 18, 2016·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Jinyuan LiLanlan Wei
Oct 14, 2016·Scientific Reports·Daeyong Jin, Hyunju Lee
Nov 5, 2016·Cell Biology International·Yilin WangLihui Lai
Apr 2, 2017·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Stephanie WottrichBenjamin Bonavida
Nov 8, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Eman Ali ToraihManal Said Fawzy
Jan 27, 2019·The Journal of Biological Chemistry·Ritu ShekharSandeep Saxena
Jun 13, 2019·Journal of Autism and Developmental Disorders·Meredith PecukonisHelen Tager-Flusberg
Oct 23, 2016·Oncotarget·Julien Masliah-PlanchonEric Pasmant
Jan 13, 2017·Topics in Magnetic Resonance Imaging : TMRI·Ahmed HassanPascal Olivier Zinn
Nov 30, 2018·Journal of Molecular Neuroscience : MN·Christelle En Lin Chua, Bor Luen Tang
Mar 25, 2014·Oncotarget·Massimiliano Agostini, Richard A Knight
Sep 27, 2018·Journal of Cellular Biochemistry·Shujun DaiZhenfu Fu
Feb 25, 2020·Journal of Oncology·Adrianna RutkowskaPiotr Rieske
Nov 15, 2016·International Journal of Molecular Medicine·Wenbo YiXingang Li
Oct 3, 2018·Analytical Methods : Advancing Methods and Applications·Richard M GraybillRyan C Bailey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.